Applied Materials looks beyond China, leans into AI and memory
Applied Materials sees 2Q25 strength amid China spending slowdown and rising competition from SiCarrier
Trump’s Middle East visit brings relief to Nvidia and AI supply chain
Industry insiders revealed that just as the market believed the rapid growth of AI was slowing down and Nvidia’s performance…
GlobalWafers to power Danish subsidiary with on-site solar plant
Topsil GlobalWafers A/S, the Danish subsidiary of GlobalWafers, is set to achieve RE100 by launching a self-built solar power plant…
Foldable iPhone components reportedly sent for testing; could reshape market dynamics in 2026
According to data from Counterpoint, global foldable phone shipments grew by just 2.9% year-over-year in 2024, with warnings that the…
Microip champions ASIC path as legacy IC design hits wall
Microip Inc., a Taipei-based ASIC startup, held a pre-Computex briefing to unveil its 2025 product roadmap. With global demand for…
Tariff truce sparks order surge at Ability Enterprise, but production still stuck in neutral
Taiwan-based electronics manufacturer Ability Enterprise held an online investor briefing on May 13 to share its first-quarter 2025 results and…
Umary and Related Products
Information regarding Umary, a product marketed as a dietary supplement
Amazon reveals new warehouse robots in push to trim manual tasks
The e-commerce giant said it plans to deploy the various technologies in the coming years as it works to boost…
Human Drug Compounding
Compounded drugs can serve an important medical need for certain patients, they also present a risk to patients.
FDA Rationale for Recognition Decision: Amoxicillin and Clavulanate against Haemophilus influenzae
FDA Rationale for Recognition Decision: Amoxicillin and Clavulanate against Haemophilus influenzae